Search results
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via AOL· 2 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
The Business Journals· 6 days ago(Nasdaq: SMMT) — led by the team that scored success with blood cancer drug developer Pharmacyclics...
FDA delays decision on Dupixent in COPD; Summit makes a bold claim
BioPharma Dive via Yahoo Finance· 5 days agoRegeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over...
Summit Therapeutics' stock surges as lung-cancer treatment vies with Merck's blockbuster
Morningstar· 6 days agoShares of Summit Therapeutics Inc. (SMMT) jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck & Co. Inc ...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 6 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks via Yahoo Finance· 3 days agoThis ETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio. Looking at...
What drug manufacturer Lonza plans to do with Genentech's soon-to-be-former Vacaville site - San...
The Business Journals· 1 day agoThe deal, announced in March, remains in the process of regulatory approval, said Hyvert, who noted...
‘I can’t explain why’: Does this dog dewormer cure cancer? These Facebook groups say yes
The Daily Dot· 6 days agoThree months later, the cancer had grown. From a cattle farm in Louisiana where she’s helping a...
Former GE General Counsel Joins Paul Weiss As Partner
LawFuel· 12 hours agoPaul, Weiss, Rifkind, Wharton & Garrison LLP announced today that Michael Holston will join the firm...
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...